EUVIMEDEUVIMED entdecken
Systematische Übersicht

Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence

Laís de Castro Carvalho Silva iD, Luís Felipe Cunha Dos Reis, Luiz Cosme Cotta Malaquias, Flávia Chiva Carvalho, Rômulo Dias Novaes, Marcos José Marques iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae155 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Laís de Castro Carvalho Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Parasitologia e Patologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Praziquantel, Schistosomiasis, Nanostructures, Schistosomicides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Brazilian agencies: Fundação do Amparo à Pesquisa do Estado de Minas Gerais, Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schistosomiasis is a neglected tropical disease caused by Schistosoma sp., and praziquantel (PZQ) is the first-line treatment. However, traditional PZQ formulations have low solubility and fast metabolism, limiting its effectiveness. Thus, nanoparticles have been proposed to improve the bioavailability and efficacy of poorly soluble antischistosomal drugs.

Aims

This systematic review used in vivo preclinical studies to map the available evidence and compare the efficacy of free PZQ and PZQ-based nanostructured formulations (N-PZQ) for schistosomiasis treatment.

Methods

PubMed, Embase, Scopus, and Web of Science were searched, and 1186 experimental studies published between 1974 and 2024 were screened. Parasitological, histopathological, pharmacokinetic, and toxicological outcomes were evaluated.

Results

Twelve relevant studies were identified exploring N-PZQ formulations based on liposomes, nanoliposomes, and nanocrystals. N-PZQ demonstrated better therapeutic efficacy than free PZQ, reducing parasite load, modifying oogram profiles, and down-regulating liver granuloma development (number and size). N-PZQ also exhibited improved pharmacokinetic profile, with enhanced bioavailability and longer half-life, as well as reduced toxicity (cytotoxicity, genotoxicity, and hepatotoxicity) compared to free PZQ.

Conclusion

PZQ-based nanostructured formulations represent a promising strategy to enhance schistosomiasis treatment by improving chemotherapy efficacy, optimizing antiparasitic responses, pharmacokinetics, and reducing drug toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PraziquantelSchistosomiasisNanostructuresSchistosomicidesAnthelminticsAnimalsBiological AvailabilityHumansNanoparticlesLiposomesSchistosomaDrug CompoundingSolubility

Stichwörter der Autor:innen

Schistosoma infectionantiparasitic chemotherapynanoparticle drug delivery systems

Substanzen

PraziquantelSchistosomicidesLiposomesAnthelmintics

Autor:innen und Institutionen

  • Departamento de Parasitologia e Patologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
  • Departamento de Biologia Estrutural, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
  • Departamento de Microbiologia e Imunologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
  • Departamento de Alimentos e Medicamentos Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.

ORCID-Profile: Laís de Castro Carvalho Silva, Marcos José Marques

Förderung

  • Brazilian agencies: Fundação do Amparo à Pesquisa do Estado de Minas Gerais
  • Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil

Zitieren

APA

de Castro Carvalho Silva, L., Cunha Dos Reis, L. F., Malaquias, L. C. C., Carvalho, F. C., Novaes, R. D., & Marques, M. J. (2025). Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae155

Vancouver

de Castro Carvalho Silva L, Cunha Dos Reis LF, Malaquias LCC, Carvalho FC, Novaes RD, Marques MJ. Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae155

BibTeX
@article{deCastroCarvalhoSilva2025,
  author = {de Castro Carvalho Silva, Laís and Cunha Dos Reis, Luís Felipe and Malaquias, Luiz Cosme Cotta and Carvalho, Flávia Chiva and Novaes, Rômulo Dias and Marques, Marcos José},
  title = {Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae155}
}
Kostenlos starten →